Education
Ph.D in Cancer Biology, Wayne State University, 2014
Current Position
Postdoctoral Fellow, Van Andel Research Institute, Michigan, USA
Publications
-
Linklater, E. S., Tovar, E. A., Essenburg, C. J., Turner, L., Madaj, Z., Winn, M. E., Melnik, M. K., Korkaya, H., Maroun, C. R., Christensen, J. G., Steensma, M. R., Boerner, J. L. and Graveel, C. R. (2016). Targeting MET and EGFR crosstalk signaling in triple-negative breast cancers. Oncotarget. [Epub ahead of print]
-
Sameni, M., Tovar, E. A., Essenburg, C. J., Chalasani, A., Linklater, E. S., Borgman, A., Cherba, D. M., Anbalagan, A., Winn, M. E., Graveel, C. R. and Sloane, B. F. (2016). Cabozantinib (XL184) Inhibits Growth and Invasion of Preclinical TNBC Models. Clin Cancer Res 22(4): 923-934.
-
Tang, K., Cai, Y., Joshi, S., Tovar, E., Tucker, S. C., Maddipati, K. R., Crissman, J. D., Repaskey, W. T. and Honn, K. V. (2015). Convergence of eicosanoid and integrin biology: 12-lipoxygenase seeks a partner. Mol Cancer 14: 111.